The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of an open-label, single-arm, multi-center study on disitamab vedotin (DV) combined with torIpalimab and radiotherapy as bladder-preserving therapy in HER2 overexpression muscle-invasive bladder cancer (MIBC; DECIDING study-stage I).
 
Ruiyun Zhang
No Relationships to Disclose
 
Di Jin
No Relationships to Disclose
 
Lei Qian
No Relationships to Disclose
 
Jun Xia
No Relationships to Disclose
 
Guangyu Wu
No Relationships to Disclose
 
Yi Li
No Relationships to Disclose
 
Jingyu Zang
No Relationships to Disclose
 
Guanglei Zhuang
No Relationships to Disclose
 
Yanli Hou
No Relationships to Disclose
 
Wei Xue
No Relationships to Disclose
 
Yiran Huang
No Relationships to Disclose
 
Haige Chen
No Relationships to Disclose